PP
EXEL icon

PDT Partners’s Exelixis EXEL Stock Holding History

PDT Partners’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,176
Closed -$351K – 978
2021
Q4 		$351K Sell
19,176
-46,102
-71% -$882K 0.03% 630
2021
Q3 		$1.38M Buy
65,278
+13,000
+25% +$241K 0.1% 297
2021
Q2 		$953K Buy
+52,278
New +$1.22M 0.06% 382
2020
Q3 		– Sell
-36,447
Closed -$865K – 763
2020
Q2 		$865K Buy
+36,447
New +$845K 0.06% 305
2017
Q1 		– Sell
-708,294
Closed -$10.6M – 489
2016
Q4 		$10.6M Sell
708,294
-2,109,170
-75% -$30.4M 0.69% 9
2016
Q3 		$36M Buy
2,817,464
+2,798,586
+14,825% +$30.3M 2.11% 1
2016
Q2 		$147K Sell
18,878
-207,467
-92% -$1.2M 0.01% 416
2016
Q1 		$905K Sell
226,345
-248,855
-52% -$1.05M 0.06% 322
2015
Q4 		$2.68M Buy
475,200
+225,200
+90% +$1.26M 0.37% 126
2015
Q3 		$1.4M Buy
+250,000
New +$1.36M 0.03% 596

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PDT Partners's EXEL Position: Q1 2022 in Review

PDT Partners sold out of Exelixis (EXEL) in Q1 2022, closing a stake of 19,176 shares — an estimated $351K sold.

PDT Partners first reported a position in EXEL in Q3 2015 and held it in 10 quarters. The position peaked at $36M in Q3 2016. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2022.

  • PDT Partners reported no remaining Exelixis position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 19,176 Exelixis shares in Q1 2022, an estimated $351K.
  • PDT Partners first reported a position in Exelixis in Q3 2015 and held it in 10 quarters.
  • PDT Partners's Exelixis position peaked at $36M in Q3 2016.
  • 363 funds tracked by Wall St. Rank held Exelixis as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.